drugset / Trial / NCT02691117

Topical Garlic Concentrate for Alopecia Areata in Children

NCT02691117 ↗

Phase 3 Terminated 8 enrolled Elena Pope Dermatology Foundation · collab
NaSingle-groupOpen-labelTreatment

Summary

Management of pediatric alopecia is particularly challenging given the chronicity of the condition, limited therapeutic response and devastating psychological effects. There is a paucity of safe and effective therapies in this population. The investigators propose to conduct and open label, prospective cohort pilot study using topical garlic concentrate ( GarlicRich) for treatment of children with alopecia areata. Study medication will be applied topically on affected area of the skin daily for 6 months. Follow up visits will occur monthly to access the efficacy and safety of the proposed treatment .

Timeline

Start
2016-01-10
Primary completion
2017-08-15
Completion
2017-12-01

Outcome

Outcome not reported

Stopped: “Lack of efficacy of the study medication”

Drugs

EvaluationDrugModalityDoseRoute
Subject garlic concentrate Unknown — Topical

Indications